Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our Level2View


Chemomab Therapeutics Reports Enrollment Of First Patient In Phase 2a Study Of CM-101 In Non-Alcoholic Steatohepatitis


Benzinga | Apr 26, 2021 06:32AM EDT

Chemomab Therapeutics Reports Enrollment Of First Patient In Phase 2a Study Of CM-101 In Non-Alcoholic Steatohepatitis






Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2026 ChartExchange LLC